Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2025-12-25 @ 2:49 AM
NCT ID:
NCT05209633
Eligibility Criteria:
Inclusion Criteria:
* Fulfill the diagnosis of chronic atrophic gastritis;
* TCM syndrome differentiation is deficiency of both qi and yin;
* Aged between 18 and 65 years old, regardless of gender;
* Volunteer to participate in this clinical trial and sign an informed consent form.
Exclusion Criteria:
* Patients with peptic ulcer, acid reflux, etc. who need PPI treatment;
* Patients with high-grade intraepithelial neoplasia of gastric mucosa or suspected malignant transformation in pathological diagnosis;
* Those who have received anti-HP treatment and related treatments in the past two weeks;
* Diabetic patients;
* Patients with severe heart, liver, kidney, lung, blood system diseases, abnormal renal function Cr test with clinical significance, and liver function ALT ≥ 1.5 times the upper limit of the normal reference value;
* People with allergies or a history of allergies to multiple drugs (two or more or the known ingredients in the drug);
* Those planning to become pregnant, pregnant or breast-feeding;
* Patients with mental illness;
* Those who have participated in other drug clinical trials within the past 3 months;
* The investigator believes that it is not suitable to participate in this clinical trial.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT05209633
Study Brief:
Protocol Section:
NCT05209633